169 related articles for article (PubMed ID: 15223962)
1. Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma.
Wolfsberger S; Fischer I; Höftberger R; Birner P; Slavc I; Dieckmann K; Czech T; Budka H; Hainfellner J
Am J Surg Pathol; 2004 Jul; 28(7):914-20. PubMed ID: 15223962
[TBL] [Abstract][Full Text] [Related]
2. Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome.
Preusser M; Wolfsberger S; Czech T; Slavc I; Budka H; Hainfellner JA
Am J Clin Pathol; 2005 Oct; 124(4):543-9. PubMed ID: 16146813
[TBL] [Abstract][Full Text] [Related]
3. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in intracranial ependymomas in children.
Figarella-Branger D; Civatte M; Bouvier-Labit C; Gouvernet J; Gambarelli D; Gentet JC; Lena G; Choux M; Pellissier JF
J Neurosurg; 2000 Oct; 93(4):605-13. PubMed ID: 11014538
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas.
Suzuki S; Oka H; Kawano N; Tanaka S; Utsuki S; Fujii K
Brain Tumor Pathol; 2001; 18(2):151-4. PubMed ID: 11908872
[TBL] [Abstract][Full Text] [Related]
6. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.
Zamecnik J; Snuderl M; Eckschlager T; Chanova M; Hladikova M; Tichy M; Kodet R
Mod Pathol; 2003 Oct; 16(10):980-91. PubMed ID: 14559980
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome.
Schrader C; Meusers P; Brittinger G; Teymoortash A; Siebmann JU; Janssen D; Parwaresch R; Tiemann M
Leukemia; 2004 Jul; 18(7):1200-6. PubMed ID: 15116121
[TBL] [Abstract][Full Text] [Related]
8. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
9. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
[TBL] [Abstract][Full Text] [Related]
10. Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker.
Preusser M; Heinzl H; Gelpi E; Höftberger R; Fischer I; Pipp I; Milenkovic I; Wöhrer A; Popovici F; Wolfsberger S; Hainfellner JA
Histopathology; 2008 Jul; 53(1):39-47. PubMed ID: 18613924
[TBL] [Abstract][Full Text] [Related]
11. Proliferation- and apoptosis-related proteins in intracranial ependymomas: an immunohistochemical analysis.
Verstegen MJ; Leenstra DT; Ijlst-Keizers H; Bosch DA
J Neurooncol; 2002 Jan; 56(1):21-8. PubMed ID: 11949823
[TBL] [Abstract][Full Text] [Related]
12. Mitosin and DNA topoisomerase IIalpha: two novel proliferation markers in the prognostication of diffuse astrocytoma patient survival.
Korkolopoulou P; Patsouris E; Konstantinidou AE; Christodoulou P; Thomas-Tsagli E; Kouzelis K; Angelidakis D; Rologis D; Davaris P
Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):207-14. PubMed ID: 11556747
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry.
Prayson RA
Ann Diagn Pathol; 1999 Feb; 3(1):11-8. PubMed ID: 9990108
[TBL] [Abstract][Full Text] [Related]
14. Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival.
Preusser M; Wolfsberger S; Haberler C; Breitschopf H; Czech T; Slavc I; Harris AL; Acker T; Budka H; Hainfellner JA
Acta Neuropathol; 2005 Feb; 109(2):211-6. PubMed ID: 15614581
[TBL] [Abstract][Full Text] [Related]
15. Ependymomas: MIB-1 proliferation index and survival.
Ritter AM; Hess KR; McLendon RE; Langford LA
J Neurooncol; 1998 Oct; 40(1):51-7. PubMed ID: 9874186
[TBL] [Abstract][Full Text] [Related]
16. Prognostic marker analysis in pediatric intracranial ependymomas.
McLendon RE; Lipp E; Satterfield D; Ehinger M; Austin A; Fleming D; Perkinson K; Lefaivre M; Zagzag D; Wiener B; Gururangan S; Fuchs H; Friedman HS; Herndon JE; Healy P
J Neurooncol; 2015 Apr; 122(2):255-61. PubMed ID: 25563815
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical staining of DNA topoisomerase IIalpha in human gliomas.
Taniguchi K; Wakabayashi T; Yoshida T; Mizuno M; Yoshikawa K; Kikuchi A; Nakashima N; Yoshida J
J Neurosurg; 1999 Sep; 91(3):477-82. PubMed ID: 10470824
[TBL] [Abstract][Full Text] [Related]
18. A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma.
Ho DM; Hsu CY; Wong TT; Chiang H
J Neurooncol; 2001 Aug; 54(1):77-85. PubMed ID: 11763426
[TBL] [Abstract][Full Text] [Related]
19. Prognostic importance of survivin, Ki-67, and topoisomerase IIα in ovarian carcinoma.
Kucukgoz Gulec U; Gumurdulu D; Guzel AB; Paydas S; Seydaoglu G; Acikalin A; Khatib G; Zeren H; Vardar MA; Altintas A
Arch Gynecol Obstet; 2014 Feb; 289(2):393-8. PubMed ID: 23974278
[TBL] [Abstract][Full Text] [Related]
20. The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients.
Korshunov A; Golanov A; Sycheva R; Timirgaz V
Cancer; 2004 Mar; 100(6):1230-7. PubMed ID: 15022291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
